Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Corvus Pharmaceuticals Inc sell StockNews.com

Corvus Pharmaceuticals Inc
Start price
€0.65
26.03.23 / 50%
Target price
-
26.03.24
Performance (%)
144.58%
End price
€1.58
27.03.24
Summary
This prediction ended on 27.03.24 with a price of €1.58. The price for Corvus Pharmaceuticals Inc massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Corvus Pharmaceuticals Inc 4.747% 4.747% 35.102%
iShares Core DAX® 2.594% -1.861% 13.242%
iShares Nasdaq 100 3.553% -2.064% 38.293%
iShares Nikkei 225® 0.687% -8.704% 17.510%
iShares S&P 500 2.209% -1.988% 27.632%

Comments by StockNews_com for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat

StockNews.com 
0
Report Share
26.03.23 Sell 144.58%
In the thread Trading Corvus Pharmaceuticals Inc
Prediction Sell
Perf. (%) 144.58%
Target price
Change
Ends at 26.03.24

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

StockNews.com 
0
Report Share
27.03.24

Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc

sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.92
03.04.23
-
03.04.24
81.96%
04.04.24

StockNews.com 
03.04.23 50%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€0.68
18.03.23
-
18.03.24
157.58%
19.03.24

StockNews.com 
18.03.23 50%